Home » Topics » Medical technology » Diagnostics

Diagnostics
RSS

Researchers prepare and test labeled iRGD peptides as cancer diagnostics

June 18, 2013

FDA agrees with proposed trial design for Methylene Blue MMX

June 17, 2013

18F-PS-TumorVue for dual-modality PET/NIRF imaging

June 17, 2013

Investigators present preclinical data for (+)-[18F]flubatine

June 14, 2013

First-in-human results presented for the imaging agent [18F]FC-119S

June 13, 2013

Qiagen expands its pipeline of personalized healthcare companion diagnostics

June 4, 2013

Omeros' OMS-824 shows binding to PDE10 in PET scans

June 3, 2013

Inostics receives CLIA certification for blood-based mutation testing

June 3, 2013

Pfizer designs approach to develop potent brain-specific PET tracers

May 31, 2013

Abbott receives license in Canada for RealTime High Risk HPV molecular diagnostic test

May 30, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...